Health Topics
Seegene's products that can solve
various diseases
0
1
•
0
2
•
0
3
•
0
4
•
Seegene’s Allplex™
HPV HR Detection
Target
14 High-risk HPVs
Interpretation
Each 14 HPV types
Reaction
One reaction
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
- HPV16
A Product
Target
14 High-risk HPVs
Interpretation
2 HPV types
Reaction
One reaction
- HPV16
- HPV18
- Other High-risk HPV
B Product
Target
14 High-risk HPVs
Interpretation
6 HPV types
Reaction
Three reaction
HPV16
HPV18
HPV45
HPV33/58
HPV31
HPV56/59/66
HPV51
HPV52
HPV35/39/68
| CE-Approved Assay | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
| Allplex™ HPV HR Detection | Positive | 114 | 38 | 152 |
| Negative | 3 | 705 | 708 | |
| Total | 117 | 743 | 860 | |
| Overall agreement | PPA | NPA |
|---|---|---|
| 95.23% (819/860) | 97.44% (114/117) | 94.89% (705/743) |
1) L Bruni et al., Human Papillomavirus and Related Diseases Report, World.
2) Latsuzbaia A et al., Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg.
